Return to search results
💡 Advanced Search Tip
Search by organization or tag to find related datasets
Patent AT-E400665-T1: [Translated] SGK AND NEDD AS DIAGNOSTIC AND THERAPEUTIC TARGETS
The invention relates to the use of a substance for the diagnostic detection of Sgk, especially Sgk1 and/or Sgk3, and/or PKB and/or Nedd, especially Nedd4-2, and to the use of active ingredients which influence glucose transport for treating diseases associated with disturbed glucose transport, and for fattening animals. The invention also relates to a diagnosis kit and a pharmaceutical composition comprising an active quantity of at least one active ingredient which influences glucose transport. The invention further relates to a method for producing transgenic animals.
Complete Metadata
| bureauCode |
[ "009:25" ] |
|---|---|
| identifier | https://healthdata.gov/api/views/f2pc-wntv |
| issued | 2025-09-05 |
| landingPage | https://healthdata.gov/d/f2pc-wntv |
| programCode |
[ "009:066" ] |
| theme |
[ "NIH" ] |
